The five dimensions of receptor pharmacology exemplified by melatonin receptors: An opinion

• Main Authors: Jean A. Boutin, Céline Legros
• Format: Article
• Language: English
• Published: Wiley 2020-02-01
• Series: Pharmacology Research & Perspectives
• Subjects: antagonism; biased ligands; dimerization; expression; GPCRs; interactome
• Online Access: https://doi.org/10.1002/prp2.556

Abstract Receptology has been complicated with enhancements in our knowledge of G‐protein‐coupled‐receptor (GPCR) biochemistry. This complexity is exemplified by the pharmacology of melatonin receptors. Here, we describe the complexity of GPCR biochemistry in five dimensions: (a) receptor expression, particularly in organs/tissues that are only partially understood; (b) ligands and receptor‐associated proteins (interactome); (c) receptor function, which might be more complex than the known G‐protein‐coupled systems; (d) ligand bias, which favors a particular pathway; and (e) receptor dimerization, which might concern all receptors coexpressed in the same cell. Thus, receptor signaling might be modified or modulated, depending on the nature of the receptor complex. Fundamental studies are needed to clarify these points and find new ways to tackle receptor functionality. This opinion article emphasizes the global questions attached to new descriptions of GPCRs and aims to raise our awareness of the tremendous complexity of modern receptology.